Kris obtained his PhD in Molecular Virology from Baylor College of Medicine in 2004 and received an NIH postdoctoral fellowship studying pancreatic cancer in Dave Tuveson’s lab at the University of Pennsylvania and then the Cancer Research UK Cambridge Institute.  He went on to be a visiting fellow at the Princess Margaret Cancer Centre in Toronto investigating novel therapeutic vulnerabilities in gastrointestinal cancers before joining the Cancer Research UK Manchester Institute Cancer Biomarker Centre as Preclinical Pharmacology Team Leader, collaborating with multiple academic groups and pharmaceutical companies to identify predictive biomarkers in lung cancer.  Kris has co-authored over 40 manuscripts peer-reviewed journals and served on the Manchester Cancer Research Centre Molecular Tumour Board for 5 years.